Works matching IS 21938261 AND DT 2024 AND VI 13 AND IP 4

Results: 11

Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 663, doi. 10.1007/s40119-024-00390-5
By:
- Jadhav, Uday M.;
- Ray, Saumitra;
- Unni, T. Govindan;
- Sawhney, J. P. S.;
- Mehta, Ashwani;
- Guha, Shantanu;
- Karnik, Rajiv D.;
- Desai, Bhupen N.;
- Khan, Aziz;
- Patel, Keyur;
- Prajapati, Jayesh S.;
- Shah, Hitesh J.;
- Reddy, Rama Krishna;
- Kumar, Sanjeev;
- Dutta, Soumya Kanti;
- Chakraborty, Saujatya;
- Ahmed, Ashfaque;
- Prasad, Ravi Vishnu;
- Chaudhary, Gaurav;
- Kumar, Amit
Publication type:
Article
Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 695, doi. 10.1007/s40119-024-00389-y
By:
- Kim, Min Chul;
- Lee, Seung Hun;
- Ahn, Joon Ho;
- Lim, Yongwhan;
- Park, Kyung-il;
- Kim, Choongki;
- Ahn, Jong-Hwa;
- Jeong, JinSeon;
- Lee, Hojoon;
- Kang, Woong Chol
Publication type:
Article
Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 797, doi. 10.1007/s40119-024-00388-z
By:
- Williams, Rhys;
- Ford, William;
- James, Alexander;
- Thomas, Kerys;
- Wong, Aaron
Publication type:
Article
Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 761, doi. 10.1007/s40119-024-00387-0
By:
- Amoey, Danial;
- Samy, Mohamed;
- Elbasha, Karim;
- Alali, Ahmad;
- Landt, Martin;
- Kurniadi, Arief;
- Nef, Holger;
- Tölg, Ralph;
- Richardt, Gert;
- Mankerious, Nader
Publication type:
Article
Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 775, doi. 10.1007/s40119-024-00386-1
By:
- Chin, Kelly M.;
- Channick, Richard;
- Kim, Nick H.;
- Ong, Rose;
- Turricchia, Stefano;
- Martin, Nicolas;
- Mitchell, Lada;
- McLaughlin, Vallerie V.
Publication type:
Article
National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 679, doi. 10.1007/s40119-024-00385-2
By:
- Thyagaturu, Harshith;
- Ali, Shafaqat;
- Seetharam, Karthik;
- Upreti, Prakash;
- Doddi, Akshith;
- Atti, Lalitsiri;
- Roma, Nicholas;
- Lacoste, Jordan L.;
- Angirekula, Aakash;
- Salami, Joseph;
- Nasir, Khurram;
- Balla, Sudarshan
Publication type:
Article
Asia–Pacific Real-World Evolocumab Use, LDL-C Reduction, Physician Goals, and Patient Perceptions: HALES Observational Study.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 737, doi. 10.1007/s40119-024-00384-3
By:
- Tse, Hung-Fat;
- Chang, Hung-Yu;
- Colquhoun, David;
- Kim, Jung-Sun;
- Poh, Kian Keong;
- Kostner, Karam;
- Hutayanon, Pisit;
- Cho, Meejin;
- Lange, Jeff;
- Kodiappan, Kamlanathan;
- Leekha, Saikiran
Publication type:
Article
A Response to: Letter to the Editor Regarding "Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)".
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 815, doi. 10.1007/s40119-024-00383-4
By:
- Attal, Sepideh
Publication type:
Article
Letter to the Editor Regarding 'Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)'.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 811, doi. 10.1007/s40119-024-00382-5
By:
- Kristen, Arnt V.;
- Tschöpe, Carsten;
- Schwarting, Stephanie;
- Siepen, Fabian aus dem
Publication type:
Article
ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 707, doi. 10.1007/s40119-024-00381-6
By:
- Sobhy, Mohamed;
- Eletriby, Adel;
- Ragy, Hany;
- Kandil, Hossam;
- Saleh, Mohamed Ayman;
- Farag, Nabil;
- Guindy, Ramez;
- Bendary, Ahmed;
- Nayel, Ahmed Mohamed Elmahmoudy;
- Shawky, Ahmed;
- Khairy, Ayman;
- Mortada, Ayman;
- Zarif, Bassem;
- Badran, Haitham;
- Khorshid, Hazem;
- Mahmoud, Kareem;
- Said, Karim;
- Leon, Khaled;
- Abdelsabour, Mahmoud;
- Tawfik, Mazen
Publication type:
Article
Milvexian: An Oral, Bioavailable Factor XIa Inhibitor.
Published in:
Cardiology & Therapy, 2024, v. 13, n. 4, p. 645, doi. 10.1007/s40119-024-00379-0
By:
- Parsa, Shyon;
- Jain, Sneha S.;
- Akinrimisi, Olu;
- Lam, Carolyn S. P.;
- Mahaffey, Kenneth W.
Publication type:
Article